Be a Smart Investor
Wednesday, October 3, 2018
ObsEva Delivers...
ObsEva SA (OBSV), which disclosed positive top line results from its phase III trial of fertility treatment Nolasiban in February, has reported encouraging additional data.
from RTT - Biotech https://ift.tt/2IAzlps
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment